• 1
    Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement Network. Transplant Data 1990–99. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources and Services Administration. Rockville, MD: US Department, of Health and Human Services, 2000.
  • 2
    Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 3
    Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 9196.
  • 4
    Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 11791185.
  • 5
    Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P, Pirenne J. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999; 68: 530535.
  • 6
    Plotkin JS, Johnson LB, Rustgi V, Kuo PC. Coronary artery disease and liver transplantation: the state of the art. Liver Transpl 2000; 6: S53S56.
  • 7
    John RP, Thuluvath PJ. Outcome of liver transplantation in patients with diabetes mellitus: a case study control study. Hepatology 2001; 34: 889895.
  • 8
    Brooks BK, Levy MF, Jennings LW et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 1996; 62: 17841787.
  • 9
    Smith CM, Davies DB, McBride MA. Liver Transplantation in the United States: a report from the Organ Procurement and Transplantation Network. In: CeckaJM, TerasakiPI (eds). Clinical Transplants. Los Angeles , CA : UCLA Tissue Typing Laboratory , 2000: 1930.
  • 10
    Onaca NO, Levy MF, Sanchez EQ et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117123.
  • 11
    Brown RS Jr, Kumar KS, Russo MW et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as preditors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8: 278284.
  • 12
    Saab S, Wang V, Ibrahim AB et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473476.
  • 13
    Baliga P, Meron RM, Turcotte JG et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992; 112: 704710; [discussion] 710–711.
  • 14
    Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986; 6: 922927.
  • 15
    Lafayette RA, Pare G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997; 48: 159164.
  • 16
    Brown RS Jr, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996; 62: 17881793.
  • 17
    Mendoza A, Fernandez F, Mutimer DJ. Liver transplantation for fulminant hepatic failure: importance of renal failure. Transpl Int 1997; 10: 5560.
  • 18
    Gonzalez E, Rimola A, Navasa M et al. Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors. J Hepatol 1998; 28: 320328.
  • 19
    Singh N, Gayowski T, Wagener MM. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients. Liver Transpl 2001; 7: 100105.
  • 20
    Sheiner PA, Magliocca JF, Bodian CA et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69: 781789.
  • 21
    Wahlstrom HE, Cooper J, Gores G, Rosen C, Wiesner R, Krom RA. Survival after liver transplantation in diabetes. Transplant Proc 1991; 23: 15651566.
  • 22
    Trail KC, Stratta RJ, Larsen JL et al. Results of liver transplantation in diabetic recipients. Surgery 1993; 114: 650656; [discussion] 656–8.
  • 23
    Blanco JJ, Herrero JI, Quiroga J et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 2001; 7: 226233.
  • 24
    Donovan CL, Marcovitz PA, Punch JD et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 11801188.
  • 25
    Carey WD, Dumot JA, Pimentel RR et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59: 859864.
  • 26
    Morris JJ, Hellman CL, Gawey GJ et al. Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cadiothorac Vasc Anesth 1995; 9: 322332.
  • 27
    Plotkin JS, Benitez RM, Kuo PC et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transplant Surg 1998; 4: 253257.
  • 28
    Plotkin JS, Scott VL, Pinna A, Dobsch BP, DeWolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transplant Surg 1996; 2: 426430.